iSpeak Blog

ISPE Women in Pharma® Panel Overview: 2024 ISPE Europe Annual Conference

Thomas Carganico
EU23_ISPE_Executive Forum

The International Society of Pharmaceutical Engineering’s (ISPE) Women in Pharma® group was established in 2017. Since its inception, it has grown to a community of more than 2,000 members who are actively engaged in educational, collaborative, and networking activities designed to bridge gender, cultural, organizational, and geographic boundaries, maximize the impact women have in the pharmaceutical industry, and help pave the way to a more equitable workforce.

In addition to the International Women in Pharma Committee, this global network thrives in ISPE Affiliates and Chapters around the world, each of which manages its own Women in Pharma initiatives for its local members by providing educational resources, mentoring activities, social and networking opportunities, and award programs aimed at helping local women in the industry gain substantial industry knowledge, participate in important conversations, serve as mentors to those entering the biopharma sector or enhancing their existing careers, and connect with like-minded people with similar goals and interests.

2024 ISPE Europe Annual Conference

Women in Pharma actively provides educational sessions at every conference that is held by ISPE, and the 2024 ISPE Europe Annual Conference, being held April 16-18 in Lisbon, Portugal, is no exception.

The conference, which draws industry professionals of all levels, from students and emerging leaders to the most senior executives in industry-wide organizations, will feature a Women in Pharma panel that will explore the intersection of healthcare equity and digitalization.

The panel will include:

Santillan is the Regional Director for Asia with Novatek International, and the current Women in Pharma International Steering Committee Chair. She is an accomplished Technical Sales Director, Business Development and Marketing professional with 25 years of experience in the information technology and services industry. She has been assisting pharmaceutical companies for the past 15 years in achieving regulatory compliance by providing technical assistance, gap analysis, computer system validation, documentation and training in the implementation and use of LIMS, digital QMS and Contamination Control solutions. Her strengths in market research and development, enterprise software, project management, strategic planning, technical implementation and training are demonstrated through a number of successful IT projects globally.

Vice President Strategic Development, Marketing & Communication - Partner
PQE Group

Carganico is the Vice President Strategic Development, Marketing & Communication – Partner with PQE Group, and an ISPE Italy Chapter Board of Directors member. Since 2013, Thomas has worked extensively within services industries across the USA, UK and Europe. He provides a strong level of experience related to Digital Branding, Marketing and Strategic Business Development. He has been with PQE Group since 2017, now serving as Vice President of Strategic Development, Marketing & Communications and as Equity Partner of the company in the US. He has also been a member of ISPE since 2020, responsible for the communications area of the Italy Affiliate Committee and serving as the lead for its Emerging Leaders. In 2022, Carganico was nominated by the ISPE Italy Affiliate to sit on its Board of Directors. During his years in business, he has provided strong insights through speeches and lectures on how to communicate effectively using scientific data and knowledge management, how to lead by example for young teams and startups, and how to foster a more inclusive work environment to generate long-term business solutions in life sciences.

Lunardi is the CEO for GENAIZ. With over 20 years of experience deploying technologies in the life sciences industry, Lunardi has gained an extensive understanding of data and systems in the industry. She has a solid knowledge of best practices and regulations applied to the life sciences industry. Her experience has led her to create GENAIZ, a unique patented Artificial Intelligence Platform that can ingest, normalize, standardize, and provide an overview of data from various systems in a flexible manner. GENAIZ is the result of Lunardi’s vision: a flexible platform dedicated to life sciences that makes data speak, quickly, by grouping data in the form of concepts in order to generate new knowledge.

Together, they will examine the opportunities and challenges presented by the rapidly advancing digital technologies in shaping a more inclusive and accessible healthcare landscape. The discussion will also address such topics as the social impact in achieving healthcare equity, the differences in healthcare in various countries and regions, policies and guidelines for patient care, comparison in between regulations worldwide, and the impact of AI on clinical trials, supply chains, and how it can leverage patients’ experience.

Current trends within these fascinating issues, which include the roles of patient advocates in shaping policies that prioritize the needs of vulnerable and underserved communities; digital platforms that collect, identify and address health disparities; and the importance of ethical data practices, patient privacy, and data-driven interventions—all of which contribute to equitable healthcare outcomes – will be addressed during this interactive forum.

We encourage conference participants to attend this dynamic session on Thursday, 18 April, 2024, from 1415-1515 (local time in Lisbon, Portugal) at the 2024 ISPE Europe Annual Conference.

Learn More & Register